SCHEMBL5722183

SCHEMBL5722183

NCc1ccc(C(=O)NCCOC(=O)N(c2ccccc2-c2ccccc2)N2CC[CH]CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 2/20 0.37
TP53 P04637 2/20 0.37
MAPT P10636 2/20 0.37
MCHR1 Q99705 1/20 0.36
SPHK2 Q9NRA0 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CD274 Q9NZQ7 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NAMPT P43490 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
HDAC1 Q13547 1/20 0.35
SPHK1 Q9NYA1 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
CFD P00746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810881 0.88 SMN1; SMN2 (0.37) HPGDALDH1A1LMNATP53MAPT
SCHEMBL4695511 0.88 PDCD1 (0.34) CD274SMN1; SMN2HDAC1
SCHEMBL5224728 0.87 HPGD (0.39) HPGDALDH1A1LMNAMCHR1SPHK2
SCHEMBL4694436 0.87 NPC1 (0.38) HPGDALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL5272930 0.85 SPHK2 (0.34) HPGDALDH1A1LMNATP53MAPT
SCHEMBL6027738 0.85 ESRRG (0.40) MAPTMCHR1CD274SMN1; SMN2NAMPT
SCHEMBL5273742 0.83 NAMPT (0.35) HPGDLMNATP53MAPTSPHK2
SCHEMBL4691523 0.82 TPSAB1 (0.36) ALDH1A1MAPTMCHR1SMN1; SMN2NAMPT
SCHEMBL5276249 0.81 SMYD2 (0.33) HPGDALDH1A1LMNASPHK2CD274
SCHEMBL5278178 0.80 ALDH1A1 (0.35) HPGDALDH1A1SPHK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685118-A2 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance, Inc. (US) 2006-08-02 EP disclosed
WO-2005051946-A2 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE, INC. (US) 2005-06-09 WO disclosed